Register entry
NODEN PHARMA DAC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 4
- Countries
- 0
Exclusivity
Patents and exclusivities
4| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8618172 | TEKTURNA HCTaliskiren hemifumarate; hydrochlorothiazide | product | Jul 2028 |
Enquiry
Common questions
- Is NODEN PHARMA DAC FDA approved?
- NODEN PHARMA DAC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.